Horse antibodies show promise against severe COVID-19 in clinical trial
NCT ID NCT04494984
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a treatment called INM005, made from antibodies produced in horses, for adults hospitalized with moderate to severe COVID-19. The goal was to see if it could help patients recover faster, measured by improvement on a standard health scale 28 days after treatment. A total of 243 participants received either the serum or a placebo, and researchers tracked their recovery and any side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Gallego de Buenos Aires
Ciudad Autonoma de Buenos Aire, Argentina
-
Clínica Adventista Belgrano
Ciudad Autonoma de Buenos Aire, Argentina
-
Clínica Zabala
Ciudad Autonoma de Buenos Aire, Argentina
-
Hospital Alta Complejidad "El Cruce" Dr. Néstor Carlos Kirchner
San Juan Bautista, Buenos Aires, Argentina
-
Hospital Centro de Salud Zenón J. Santillán
San Miguel de Tucumán, Tucumán Province, Argentina
-
Hospital Español de Buenos Aires
Ciudad Autonoma de Buenos Aire, Argentina
-
Hospital Italiano de Buenos Aires
Buenos Aires, C1199ABH, Argentina
-
Hospital Italiano de La Plata
La Plata, Buenos Aires, Argentina
-
Hospital Municipal Dr. Diego E. Thompson
San Martín, Buenos Aires, Argentina
-
Hospital Municipal Emilio Zerboni
San Antonio de Areco, Buenos Aires, Argentina
-
Hospital Muñiz
Buenos Aires, C1282AEN, Argentina
-
Hospital Pirovano
Buenos Aires, C1428, Argentina
-
Hospital Prof. Dr. Bernardo A. Houssay
Florida, Buenos Aires, Argentina
-
Hospital Provincial Neuquén "Dr. Eduardo Castro Rendón"
Neuquén, Neuquén Province, Argentina
-
Hospital de Cuenca Alta
Canuelas, Buenos Aires, B1814, Argentina
-
Instituto Medico Platense
La Plata, Buenos Aires, B1900AVG, Argentina
-
Sanatorio Agote
Ciudad Autonoma de Buenos Aire, Argentina
-
Sanatorio Guemes
Buenos Aires, C1180AAD, Argentina
-
Sanatorio Sagrado Corazón
Ciudad Autonoma de Buenos Aire, Argentina
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?